1. Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin. (30th June 2015) Authors: van Hasselt, JGC; Gupta, A; Hussein, Z; Beijnen, JH; Schellens, JHM; Huitema, ADR Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 7(2015:Jul.) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration‐Resistant Prostate Cancer Treatment With Eribulin. (30th June 2015) Authors: van Hasselt, JGC; Gupta, A; Hussein, Z; Beijnen, JH; Schellens, JHM; Huitema, ADR Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 7(2015:Jul.) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics. (10th February 2017) Authors: Nguyen, THT; Mouksassi, M‐S; Holford, N; Al‐Huniti, N; Freedman, I; Hooker, AC; John, J; Karlsson, MO; Mould, DR; Pérez Ruixo, JJ; Plan, EL; Savic, R; van Hasselt, JGC; Weber, B; Zhou, C; Comets, E; Mentré, F Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 2(2017) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗